Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Breast Cancer Res Treat. 2023 Feb 28;198(3):487–498. doi: 10.1007/s10549-023-06889-0

Figure 1.

Figure 1.

Administration schedule of veliparib (V), carboplatin (C) and paclitaxel (T) in the dose-escalation and dose-expansion phase. D=day. The blue arrow in the center represents the protocol amendment. Doses of veliparib, carboplatin, and paclitaxel at each dose level (DL) in the dose-escalation and in the dose- expansion phase. AUC=area under the curve; DL=dose level; BID=twice daily.